Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?-Reference-Cited by-同舟云学术

Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?

Published:2016-12-02 Issue:5 Volume:24 Page:1234-1241
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Jackson Sara L.,Frederick Paul D.,Pepe Margaret S.,Nelson Heidi D.,Weaver Donald L.,Allison Kimberly H.,Carney Patricia A.,Geller Berta M.,Tosteson Anna N. A.,Onega Tracy,Elmore Joann G.

Funder

National Cancer Institute

Breast Cancer Surveillance Consortium

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-016-5695-0.pdf

Reference22 articles.

1. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605–13.

2. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716–26.

3. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361(9352):125–9.

4. Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast—risk assessment and management options. N Engl J Med. 2015;372:78–89.

5. Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362–7.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer;EJNMMI Research;2024-03-04

2. Advancements in computer vision and pathology: Unraveling the potential of artificial intelligence for precision diagnosis and beyond;Advances in Cancer Research;2024

3. Photon Absorption Remote Sensing Imaging of Breast Needle Core Biopsies Is Diagnostically Equivalent to Gold Standard H&E Histologic Assessment;Current Oncology;2023-11-06

4. Photon Absorption Remote Sensing Imaging of Breast Needle Core Biopsies is Diagnostically Equivalent to Gold Standard H&E Histologic Assessment;2023-08-09

5. Should low-risk DCIS lose the cancer label? An evidence review;Breast Cancer Research and Treatment;2023-04-19